Filippo Mazzi: IVIG as an Alternative Therapy for Acute Chest Syndrome in Patients with Sickle Cell Disease
Filippo Mazzi, Medical Doctor at Integrated University Hospital of Verona, Italy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Excited to share our latest publication in Haematologica.
What can we do when a life-saving treatment is not an option?
We report two challenging cases of acute chest syndrome in patients with sickle cell disease who could not receive blood transfusions for religious reasons. We explored the use of intravenous immunoglobulins (IVIG) as an alternative therapeutic approach, with encouraging clinical outcomes.
These cases highlight how innovative and flexible treatment strategies can help address complex clinical scenarios in sickle cell disease and drive innovation in patient care.
Grateful to all co-authors and collaborators for this work.”
Title: Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah’s Witnesses with sickle cell disease
Authors: Francesca Begali, Jacopo Ceolan, Silvia Vitale, Simone Villaboni, Matteo Merlo, Rachele Zamperini, Roberto Bertazzo, Soraia Ribeiro Luz, Filippo Mazzi, Lucia De Franceschi
Read the Full Article on Haematologica.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 13:43Edward Lee Carter: Optimizing Anticoagulation in Cirrhosis Beyond the Lab Numbers
-
Aug 14, 2026, 13:39Amr Saad: What Tips You Toward Cerebral Venous Thrombosis Over IIH?
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma